Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric teriflunomide versus placebo trial in relapsing multiple sclerosis
2011-005249-12Phase 3Completed
- Sponsor
- Sanofi
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in multiple sclerosis (MS) comparing Teriflunomide with Placebo (2 arms). Primary endpoint: Time to first clinical relapse after randomization. Started Feb 2014; status: completed.
02
Drugs
teriflunomide
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2011-005249-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005249-12.